New research on a promising treatment against type 1 diabetes funded by the European Commission
More than 40 million individuals worldwide are affected by type 1 diabetes, which is the most common chronic disease in children and adolescents. Today’s primary treatment for diabetes is insulin […]
VANGUARD partners meet for the first time
Representatives from the eight VANGUARD partners travelled from across Europe to Igls in Austria to officially kick-off the project. The meeting took place on the 25th January 2020 and offered […]
VANGUARD selected for Horizon 2020 funding
Our VANGUARD proposal to develop a new bioartificial pancreas to cure type 1 diabetes has been selected for funding by the European Commission. Under the call SC1-BHC-07-2019 Regenerative medicine: from […]
